Refractory cytopenia with multilineage dysplasia
| Refractory cytopenia with multilineage dysplasia | |
|---|---|
| Specialty | Hematology |
Refractory cytopenia with multilineage dysplasia is a form of myelodysplastic syndrome.[1]
It is abbreviated "RCMD".[2][3]
References
[edit]- ^ Rosati S, Mick R, Xu F, et al. (January 1996). "Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome". Leukemia. 10 (1): 20–6. PMID 8558932.
- ^ Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
- ^ Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862. S2CID 3519094.[dead link]
External links
[edit]
 | This article about a disease of the blood or immune system is a stub. You can help Wikipedia by expanding it. |